These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 20148713)
1. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin. Taneri F; Ozcan I; Guneri T Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713 [TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541 [TBL] [Abstract][Full Text] [Related]
6. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. Zhang J; Wang L; Gao C; Zhang L; Xia H J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444 [TBL] [Abstract][Full Text] [Related]
7. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole. Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772 [TBL] [Abstract][Full Text] [Related]
8. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans. He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593 [TBL] [Abstract][Full Text] [Related]
10. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes. Aggarwal S; Singh PN; Mishra B Pharmazie; 2002 Mar; 57(3):191-3. PubMed ID: 11933849 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246 [TBL] [Abstract][Full Text] [Related]
12. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243 [TBL] [Abstract][Full Text] [Related]
13. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex. Wang L; Zeng F; Zong L Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202 [TBL] [Abstract][Full Text] [Related]
14. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets. Fridriksdóttir H; Loftsson T; Gudmundsson JA; Bjarnason GJ; Kjeld M; Thorsteinsson T Pharmazie; 1996 Jan; 51(1):39-42. PubMed ID: 8999433 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers. Nie S; Zhang S; Pan W; Liu Y Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949 [TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex. Zheng Y; Chow AH Drug Dev Ind Pharm; 2009 Jun; 35(6):727-34. PubMed ID: 19514988 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734 [TBL] [Abstract][Full Text] [Related]
19. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems. Onyeji CO; Omoruyi SI; Oladimeji FA Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103 [TBL] [Abstract][Full Text] [Related]
20. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits. Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]